Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm?

被引：123

作者：

Spyropoulos, A. C. ^{[1
]}

Goldenberg, N. A. ^{[2
,3
,4
]}

Kessler, C. M. ^{[5
,6
,7
]}

Kittelson, J. ^{[8
]}

Schulman, S. ^{[9
,10
]}

Turpie, A. G. G. ^{[9
,10
]}

Cutler, N. R. ^{[11
]}

Hiatt, W. R. ^{[12
,13
]}

Halperin, J. L. ^{[14
]}

机构：

[1] Univ Rochester, Med Ctr, Dept Med, Div Hematol Oncol, Rochester, NY 14642 USA

[2] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Hematol, Baltimore, MD 21205 USA

[3] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA

[4] Univ S Florida, All Childrens Hosp, All Childrens Res Inst, Johns Hopkins Med, St Petersburg, FL 33701 USA

[5] Georgetown Univ, Med Ctr, Dept Med, Washington, DC 20007 USA

[6] Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20007 USA

[7] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

[8] Univ Colorado, Sch Publ Hlth, Dept Biostat, Aurora, CO USA

[9] McMaster Univ, Div Hematol & Thromboembolism, Hamilton, ON, Canada

[10] McMaster Univ, Dept Med, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada

[11] Worldwide Clin Trials, Beverly Hills, CA USA

[12] Univ Colorado, Sch Med, Div Cardiol, Aurora, CO USA

[13] Univ Colorado, Sch Med, CPC Clin Res, Aurora, CO USA

[14] Mt Sinai Sch Med, Cardiovasc Inst, New York, NY USA

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2012年 / 10卷 / 12期

关键词：

ATRIAL-FIBRILLATION; WARFARIN;

D O I：

10.1111/jth.12005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Spyropoulos AC, Goldenberg NA, Kessler CM, Kittelson J, Schulman S, Turpie AGG, Cutler NR, Hiatt WR, Halperin JL. Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm? J Thromb Haemost 2012; 10: 26214.

引用

页码：2621 / 2624

页数：4

共 9 条

[1] Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable [J].

Connolly, Stuart J. ;

Eikelboom, John W. ;

Ng, Jennifer ;

Hirsh, Jack ;

Yusuf, Salim ;

Pogue, Janice ;

de Caterina, Raffaele ;

Hohnloser, Stefan ;

Hart, Robert G. .

ANNALS OF INTERNAL MEDICINE, 2011, 155 (09) :579-U41

[2] Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].

Connolly, Stuart J. ;

Ezekowitz, Michael D. ;

Yusuf, Salim ;

Eikelboom, John ;

Oldgren, Jonas ;

Parekh, Amit ;

Pogue, Janice ;

Reilly, Paul A. ;

Themeles, Ellison ;

Varrone, Jeanne ;

Wang, Susan ;

Alings, Marco ;

Xavier, Denis ;

Zhu, Jun ;

Diaz, Rafael ;

Lewis, Basil S. ;

Darius, Harald ;

Diener, Hans-Christoph ;

Joyner, Campbell D. ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151

[3] Evaluating Rivaroxaban for Nonvalvular Atrial Fibrillation - Regulatory Considerations [J].

Fleming, Thomas R. ;

Emerson, Scott S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (17) :1557-1559

[4] Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model [J].

Goldenberg, Neil A. ;

Spyropoulos, Alex C. ;

Halperin, Jonathan L. ;

Kessler, Craig M. ;

Schulman, Sam ;

Turpie, Alexander G. G. ;

Skene, Allan M. ;

Cutler, Neal R. ;

Hiatt, William R. .

BLOOD, 2011, 117 (07) :2089-2092

[5] Apixaban versus Warfarin in Patients with Atrial Fibrillation [J].

Granger, Christopher B. ;

Alexander, John H. ;

McMurray, John J. V. ;

Lopes, Renato D. ;

Hylek, Elaine M. ;

Hanna, Michael ;

Al-Khalidi, Hussein R. ;

Ansell, Jack ;

Atar, Dan ;

Avezum, Alvaro ;

Cecilia Bahit, M. ;

Diaz, Rafael ;

Easton, J. Donald ;

Ezekowitz, Justin A. ;

Flaker, Greg ;

Garcia, David ;

Geraldes, Margarida ;

Gersh, Bernard J. ;

Golitsyn, Sergey ;

Goto, Shinya ;

Hermosillo, Antonio G. ;

Hohnloser, Stefan H. ;

Horowitz, John ;

Mohan, Puneet ;

Jansky, Petr ;

Lewis, Basil S. ;

Luis Lopez-Sendon, Jose ;

Pais, Prem ;

Parkhomenko, Alexander ;

Verheugt, Freek W. A. ;

Zhu, Jun ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11) :981-992

[6] Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation [J].

Patel, Manesh R. ;

Mahaffey, Kenneth W. ;

Garg, Jyotsna ;

Pan, Guohua ;

Singer, Daniel E. ;

Hacke, Werner ;

Breithardt, Guenter ;

Halperin, Jonathan L. ;

Hankey, Graeme J. ;

Piccini, Jonathan P. ;

Becker, Richard C. ;

Nessel, Christopher C. ;

Paolini, John F. ;

Berkowitz, Scott D. ;

Fox, Keith A. A. ;

Califf, Robert M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (10) :883-891

[7] Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48) [J].

Ruff, Christian T. ;

Giugliano, Robert P. ;

Antman, Elliott M. ;

Crugnale, Sharon E. ;

Bocanegra, Tomas ;

Mercuri, Michele ;

Hanyok, James ;

Patel, Indravadan ;

Shi, Minggao ;

Salazar, Dan ;

McCabe, Carolyn H. ;

Braunwald, Eugene .

AMERICAN HEART JOURNAL, 2010, 160 (04) :635-U266

[8] Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients [J].

Schulman, S ;

Kearon, C .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (04) :692-694

[9] New Antithrombotic Drugs Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J].

Weitz, Jeffrey I. ;

Eikelboom, John W. ;

Samama, Meyer Michel .

CHEST, 2012, 141 (02) :E120S-E151S

← 1 →